Page 25 of 291 · 8,722 total

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00643

Samsung has filed a petition for Director rehearing of a PTAB decision that denied institution of an IPR on iCashe’s mobile‑payment patent. The petition argues that recent USPTO policy changes were made without required rulemaking and ignored Samsung’s Sotera stipulation, violating the APA and due‑process rights.

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00642

Samsung Electronics petitions the PTAB Director to rehear a discretionary denial of institution in IPR2025-00642, arguing that recent USPTO guidance changes violated the APA and due‑process rights. The petition contends the Board ignored Samsung’s Sotera stipulation and misapplied “settled expectations.”

patent denied · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00644

iCashe, Inc. opposes Samsung’s request for Director Review of discretionary denials of seven IPR petitions covering patent 9,208,423. The patent owner argues the Director properly applied the Boalick and Stewart memos and that Samsung’s Sotera stipulation and settled‑expectations arguments were insufficient to overturn the denial.

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00644

Samsung has filed a Director Review request seeking reversal of the USPTO’s discretionary denial to institute six IPRs against iCashe’s patent 9,208,423.

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00643

Samsung filed a petition asking the USPTO Director to rehear the denial of institution for several IPRs targeting iCashe’s patent. The request challenges the Director’s discretionary denial under § 314(a).

patent denied · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00642

Samsung’s request for Director Review of the PTAB’s discretionary denial of its IPRs against iCashe’s payment patents was rejected. The Board affirmed that the Director properly applied the Boalick and Stewart memoranda and that Samsung lacks a protected due‑process interest.

patent terminated or settled · Oct 3, 2025

Amazon.com, Inc. et al. v.AlmondNet, Inc.

· IPR2025-00545

Amazon and AlmondNet settled their IPR over patent 8,494,904 and jointly requested the Board keep the settlement agreement confidential and terminate the proceeding.

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00642

Samsung filed a Director Review request after the USPTO denied institution of multiple IPRs targeting iCashe’s mobile‑payment patent. The petition seeks rehearing and submits P‑TACTS requests to keep the challenges alive.

patent all challenged claims unpatentable · Oct 3, 2025

Amazon.com, Inc. et al. v.AlmondNet, Inc.

· IPR2025-00545

The PTAB held that all of the claims challenged by Amazon in IPR2022‑01436 are unpatentable, finding them obvious over a combination of prior‑art references covering user profiling and ad targeting.

patent terminated or settled · Oct 3, 2025

Amazon.com, Inc. et al. v.AlmondNet, Inc.

· IPR2025-00545

Amazon and AlmondNet have reached a settlement and jointly moved to terminate the IPR over U.S. Patent 8,494,904, which covers online advertising technologies. The Board is asked to end the proceeding and keep the settlement confidential.

patent terminated or settled · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD., et al. v.Sinotechnix LLC

· IPR2025-00334

Samsung and Sinotechnix settled their IPR dispute over U.S. Patent 9,412,913 before the trial was instituted. The Board terminated the proceeding and ordered the settlement agreement to be kept confidential.

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD., et al. v.Sinotechnix LLC

· IPR2025-00334

Samsung and Sinotechnix have settled their OLED display patent dispute and jointly moved to terminate the IPR, requesting the settlement be kept confidential.

patent · Oct 3, 2025

AdvanCell Pty Ltd. v.Sciencons AS et al.

· PGR2025-00029

AdvanCell has petitioned the PTAB to invalidate Sciencons’ 603 patent covering a radioisotope generator for targeted alpha‑therapy, arguing anticipation, obviousness, and lack of enablement. The petition seeks cancellation of all 20 claims.

patent · Oct 3, 2025

Nintendo Co. Ltd. et al. v.Resonant Systems, Inc.

· IPR2025-00680

Nintendo has filed an IPR petition challenging claims 2 and 3 of Resonant’s haptic‑feedback patent, arguing obviousness over a suite of prior‑art references and seeking joinder with a related Apple IPR. The petition highlights favorable Fintiv factors and disputes the patent owner’s claim constructions.

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00644

Samsung has filed a petition for IPR against iCashe’s 9,208,423 patent covering a mobile phone that emulates a magnetic‑card swipe. The petition relies on Doughty, Bursch and Fox references to argue obviousness under §103 and contends that discretionary denial does not apply.

patent · Oct 3, 2025

Microsoft Corporation et al. v.Dialect, LLC

· IPR2025-00655

Microsoft has filed an IPR petition seeking to invalidate claims 12 and 13 of Dialect’s 7,640,160 patent, arguing they are obvious over Maes, Coffman, and Ross references. The petition also argues the Board should not deny institution under §§ 325(d) and 314(a).

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00643

Samsung Electronics has filed an IPR petition challenging iCashe’s ’156 patent covering mobile‑phone magnetic‑stripe emulation. The petition relies on Doughty and Fox as prior art and argues that the examiner failed to consider these references, making the claims unpatentable under §§102 and 103.

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD. et al. v.iCashe, Inc.

· IPR2025-00642

Samsung has petitioned the PTAB to invalidate iCashe’s 8,403,219 patent covering smartcard integration in mobile phones. The petition relies on the Fox and Takekawa references to argue anticipation and obviousness under §§102 and 103. The Board has yet to decide whether to institute the review.

patent · Oct 3, 2025

SAMSUNG ELECTRONICS CO., LTD., et al. v.Sinotechnix LLC

· IPR2025-00334

Samsung Electronics has filed an IPR petition seeking to invalidate claims 1‑4 and 6 of Sinotechnix’s 9,412,913 LED‑package patent, asserting obviousness and anticipation based on five prior‑art references.

patent · Oct 3, 2025

Amazon.com, Inc. et al. v.AlmondNet, Inc.

· IPR2025-00545

Amazon has filed an IPR petition seeking to invalidate dozens of claims of AlmondNet’s ’904 patent covering URL‑redirect based user profiling for targeted ads.

patent instituted · Oct 3, 2025

AdvanCell Pty Ltd. v.Sciencons AS et al.

· PGR2025-00029

AdvanCell Pty Ltd.'s PGR against Sciencons AS et al. was instituted by the PTAB, finding sufficient evidence that several claims are unpatentable. The Board adopted Petitioner's interpretation of a key time-based limitation in Claim 20 during the institution phase.

patent instituted · Oct 3, 2025

Amazon.com, Inc. et al. v.AlmondNet, Inc.

· IPR2025-00545

Amazon successfully challenged the '904 patent, leading to its institution after demonstrating a reasonable likelihood of unpatentability. The challenge focused on obviousness (35 U.S.C. § 103) regarding automated profile collection and data targeting methods.

patent mixed - some claims cancelled, some upheld · Oct 3, 2025

Nintendo Co. Ltd. et al. v.Resonant Systems, Inc.

· IPR2025-00680

Apple Inc. successfully demonstrated obviousness against certain claims of Resonant Systems, Inc.'s patent (8860337) in a PTAB Final Written Decision. The Board found that Claims 2 and 3 were unpatentable over various combinations of prior art references under 35 U.S.C. § 103(a).

patent all challenged claims unpatentable · Oct 2, 2025

Neurocrine Biosciences, Inc. v.Spruce Biosciences, Inc.

· PGR2025-00032

The PTAB held that Neurocrine Biosciences’ challenge to Spruce Biosciences’ ’201 patent succeeded; all 19 claims were found unpatentable for lack of written description under §112(a).

patent all challenged claims unpatentable · Oct 2, 2025

Neurocrine Biosciences, Inc. v.Spruce Biosciences, Inc.

· PGR2025-00032

The PTAB held that Neurocrine Biosciences' challenge succeeded; claims 1‑25 of Spruce Biosciences' ’908 patent were found unpatentable for lack of written description under 35 U.S.C. §112(a). The Board applied Ariad standards and rejected the genus claim.

patent · Oct 2, 2025

Neurocrine Biosciences, Inc. v.Spruce Biosciences, Inc.

· PGR2025-00032

Neurocrine Biosciences has filed a PTAB post‑grant review petition seeking to invalidate Spruce Biosciences’ 11,007,201 patent covering CRF1 receptor antagonists for congenital adrenal hyperplasia. The petition alleges anticipation, obviousness, and lack of written description. Discretionary denial is contested.

patent · Oct 2, 2025

Neurocrine Biosciences, Inc. v.Spruce Biosciences, Inc.

· PGR2025-00032

Neurocrine Biosciences has petitioned the PTAB to invalidate Spruce Biosciences' U.S. Patent 10,849,908 covering CRF1 receptor antagonists for congenital adrenal hyperplasia, arguing lack of written description, enablement, and that prior art anticipates or renders obvious the claims.

patent terminated or settled · Oct 2, 2025

Samsung Electronics Co., Ltd. et al. v.HEADWATER RESEARCH LLC

· IPR2025-00484

Samsung and Headwater have settled their IPR dispute, filing a joint motion to terminate the proceedings and withdrawing pending review requests.

patent · Oct 2, 2025

Samsung Electronics Co., Ltd. et al. v.HEADWATER RESEARCH LLC

· IPR2025-00484

Headwater Research filed a response to Samsung’s request for Director Review of the PTAB’s denial of institution. The patent owner argues the Vidal Memo recission was proper, the change‑in‑position doctrine does not apply, and discretionary denial is statutorily authorized.

patent terminated or settled · Oct 2, 2025

Samsung Electronics Co., Ltd. et al. v.HEADWATER RESEARCH LLC

· IPR2025-00483

Samsung and HEADWATER reached a settlement, leading to a joint motion to terminate IPR2025-00483 and related proceedings. The petitioner withdrew its request for Director Review.

1 •••242526•••291
Arctic Invent — IP Strategy

Dealing with a patent challenge?

Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.

Talk to our patent team →